» Articles » PMID: 2804539

Effects of Yohimbine on Submaxillary Salivation in Dogs

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1989 Sep 1
PMID 2804539
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

1. The effects of yohimbine (0.5 mg kg-1 i.v.) on both resting and parasympathetic and sympathetic stimulation-induced submaxillary salivary responses were investigated in the anaesthetized dog. 2. Salivary secretion was increased significantly for a period of 45 min following an injection of yohimbine. 3. Sectioning of the chorda tympani (but not the cervical sympathetic) nerve abolished the yohimbine-induced increase in resting salivary secretion and potentiated that elicited by electrical stimulation of the chorda tympani nerve. 4. These results show that yohimbine increases submaxillary secretion by inhibition of presynaptic alpha 2-adrenoceptors located on the chorda tympani, which inhibit cholinergic transmission.

Citing Articles

Artificial Saliva for Therapeutic Management of Xerostomia: A Narrative Review.

Alhejoury H, Mogharbel L, Al-Qadhi M, Shamlan S, Alturki A, Babatin W J Pharm Bioallied Sci. 2022; 13(Suppl 2):S903-S907.

PMID: 35017895 PMC: 8686887. DOI: 10.4103/jpbs.jpbs_236_21.


Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Samuels E, Szabadi E Curr Neuropharmacol. 2009; 6(3):254-85.

PMID: 19506724 PMC: 2687931. DOI: 10.2174/157015908785777193.


Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in man.

Barbe P, Galitzky J, Riviere D, Senard J, Lafontan M, Garrigues M Br J Clin Pharmacol. 1993; 36(1):25-30.

PMID: 8373709 PMC: 1364550. DOI: 10.1111/j.1365-2125.1993.tb05887.x.


Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.

Bagheri H, Picault P, Schmitt L, Houin G, Berlan M, Montastruc J Br J Clin Pharmacol. 1994; 37(1):93-6.

PMID: 8148228 PMC: 1364719. DOI: 10.1111/j.1365-2125.1994.tb04248.x.


Mechanisms of sympathetic enhancement and inhibition of parasympathetically induced salivary secretion in anaesthetized dogs.

Lung M Br J Pharmacol. 1994; 112(2):411-6.

PMID: 8075858 PMC: 1910338. DOI: 10.1111/j.1476-5381.1994.tb13087.x.


References
1.
Goldberg M, Robertson D . Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor. Pharmacol Rev. 1983; 35(3):143-80. View

2.
Armstrong J, Scatton B, Cavero I . Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat. J Pharmacol Exp Ther. 1982; 223(2):524-35. View

3.
Kaniucki M, STEFANO F, Perec C . Clonidine inhibits salivary secretion by activation of postsynaptic alpha 2-receptors. Naunyn Schmiedebergs Arch Pharmacol. 1984; 326(4):313-6. DOI: 10.1007/BF00501435. View

4.
Moore N, Chadelaud M, Huchet A, Saligaut C, Daoust M, Lhuintre J . Urethane interferes with the alpha 2-agonist guanfacine. J Cardiovasc Pharmacol. 1984; 6(5):973-4. DOI: 10.1097/00005344-198409000-00036. View

5.
Kaniucki M, Elverdin J, STEFANO F, Perec C . Effects of guanabenz and guanfacine on postsynaptic alpha 2-adrenoceptors in the rat submaxillary and parotid glands. Naunyn Schmiedebergs Arch Pharmacol. 1985; 329(3):289-92. DOI: 10.1007/BF00501882. View